Welcome to LookChem.com Sign In|Join Free

CAS

  • or

56187-47-4

Post Buying Request

56187-47-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

56187-47-4 Usage

Originator

Cefazedone Sodium,Arocor Holdings Inc.

Uses

Semi-synthetic cephalosporin antibiotic. Antibacterial.

Definition

ChEBI: A cephalosporin compound having [(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl and [(3,5-dichloro-4-oxopyridin-1(4H)-yl)acetamido side-groups.

Manufacturing Process

A solution of 1 eq. of the tert-butyl ester of 7-aminocephalosporanic acid and 1 eq. of dicyclohexylcarbodiimide in 100 ml of methylene chloride/DMF (1:1) is cooled to 0°C. The mixture is combined with 1 eq. of 3,5-dichloro-4- pyridone-1-acetic acid; after 5 min the ice bath is removed and the mixture agitated for another 30 min at 25°C. The thus-formed urea is filtered off and the filtrate filtered over silica gel (eluent: ethyl acetate/1% methanol). The solvent is concentrated by evaporation, and the thus-obtained tert-butyl ester of 7-(3,5-dichloro-1,4-dihydro-4-oxo-1-pyridylacetamido)cephalosporanic acid is crystallized from ether.1 eq. of the tert-butyl ester is dissolved in 30 ml of trifluoroacetic acid. After 30 minutes, the solution is evaporated and the thus-produced 7-(3,5-dichloro- 1,4-dihydro-4-oxo-1-pyridylacetamido)cephalosporanic acid crystallized from ether.1 eq. of the obtained 7-(3,5-dichloro-1,4-dihydro-4-oxo-1-pyridylacetamido) cephalosporanic acid is dissolved in 60 ml of saturated aqueous sodium bicarbonate solution at a pH of below 7 and combined with 1 eq. of 5-methyl- 1,3,4-thiadiazole-2-thiol in 20 ml of acetone. The reaction solution is agitated for 2 hours at 80°C and at a pH of 6.3 under a nitrogen atmosphere. The acetone is thereupon removed, the solution is washed with ether and acidified to pH 2. The thus-obtained 3-(1-methyltetrazolyl-5-mercaptomethyl)-7-(3,5- dichloro-1,4-dihydro-4-oxo-1-pyridylacetamido)-3-cephem-4-carboxylic acid is filtered off and dried. IR spectrum confirmed the structure of cefazedone.In practice it is usually used as sodium salt.

Therapeutic Function

Antibiotic

Check Digit Verification of cas no

The CAS Registry Mumber 56187-47-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,1,8 and 7 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 56187-47:
(7*5)+(6*6)+(5*1)+(4*8)+(3*7)+(2*4)+(1*7)=144
144 % 10 = 4
So 56187-47-4 is a valid CAS Registry Number.
InChI:InChI=1/C18H19Cl2N5O5S3/c1-7-22-23-18(33-7)32-6-8-5-31-16-12(15(28)25(16)13(8)17(29)30)21-11(26)4-24-2-9(19)14(27)10(20)3-24/h9-10,12,16H,2-6H2,1H3,(H,21,26)(H,29,30)

56187-47-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (6R,7R)-7-[[2-(3,5-dichloro-4-oxopyridin-1-yl)acetyl]amino]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

1.2 Other means of identification

Product number -
Other names Refosporen

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:56187-47-4 SDS

56187-47-4Synthetic route

C12H13Cl2NO4

C12H13Cl2NO4

C11H12N4O3S3*ClH

C11H12N4O3S3*ClH

cefazedone
56187-47-4

cefazedone

Conditions
ConditionsYield
With triethylamine In acetonitrile at 0 - 5℃; for 0.5h; pH=6.8;95%
C15H12BrCl2N3O5S

C15H12BrCl2N3O5S

2-mercapto-5-methyl-1,3,4-thiadiazole
29490-19-5

2-mercapto-5-methyl-1,3,4-thiadiazole

cefazedone
56187-47-4

cefazedone

Conditions
ConditionsYield
With triethylamine In ethanol for 10h; Solvent; Reagent/catalyst; Reflux;93.86%
2-(3,5-dichloro-4-oxopyridine-1(4H)-yl)acetic acid
56187-37-2

2-(3,5-dichloro-4-oxopyridine-1(4H)-yl)acetic acid

(6R,7R)-7-amino-3-(5-methyl-1,3,4-thiadiazol-2-ylthiomethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
30246-33-4

(6R,7R)-7-amino-3-(5-methyl-1,3,4-thiadiazol-2-ylthiomethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

cefazedone
56187-47-4

cefazedone

Conditions
ConditionsYield
With ortho-iodophenylboronic acid In toluene Solvent; Reflux;93%
(i) SOCl2, DMF, (ii) /BRN= 629621/, Et3N, CH2Cl2; Multistep reaction;
2-(3,5-dichloro-4-oxopyridine-1(4H)-yl)acetic acid
56187-37-2

2-(3,5-dichloro-4-oxopyridine-1(4H)-yl)acetic acid

cefazedone
56187-47-4

cefazedone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: 1,3,5-trichloro-2,4,6-triazine; triethylamine / N,N-dimethyl-formamide / 1.33 h / Cooling with ice
1.2: 1.75 h / 20 °C
2.1: N-Bromosuccinimide; dibenzoyl peroxide / tetrachloromethane / 4 h / Reflux
3.1: triethylamine / ethanol / 10 h / Reflux
View Scheme
3-deacetyloxy-7-aminocephalosporanic acid
22252-43-3, 26395-99-3, 70287-30-8, 72059-35-9

3-deacetyloxy-7-aminocephalosporanic acid

cefazedone
56187-47-4

cefazedone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: 1,3,5-trichloro-2,4,6-triazine; triethylamine / N,N-dimethyl-formamide / 1.33 h / Cooling with ice
1.2: 1.75 h / 20 °C
2.1: N-Bromosuccinimide; dibenzoyl peroxide / tetrachloromethane / 4 h / Reflux
3.1: triethylamine / ethanol / 10 h / Reflux
View Scheme
7-Aminocephalosporanic acid
957-68-6

7-Aminocephalosporanic acid

cefazedone
56187-47-4

cefazedone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: boron trifluoride diethyl etherate; acetic acid / 5 - 10 °C
2: triethylamine / acetonitrile / 0.5 h / 0 - 5 °C / pH 6.8
View Scheme
cefazedone
56187-47-4

cefazedone

(6R,7R)-3-[[(5-methyl-1,3,4-thiadiazolyl-2-yl)thio]methyl]-7-[2-(3,5-dichloro-4-pyridone-1-acetylamido)]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt
63521-15-3

(6R,7R)-3-[[(5-methyl-1,3,4-thiadiazolyl-2-yl)thio]methyl]-7-[2-(3,5-dichloro-4-pyridone-1-acetylamido)]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt

Conditions
ConditionsYield
Stage #1: cefazedone With triethylamine In methanol at 0 - 10℃; for 0.5h;
Stage #2: With sodium 2-ethylhexanoic acid In methanol; acetone at 0 - 10℃; for 3.5h;
95.2%
Stage #1: cefazedone With triethylamine In methanol at 0 - 10℃; for 0.5h;
Stage #2: With sodium 2-ethylhexanoic acid In acetone at 0 - 10℃; for 3.5h;
95.2%

56187-47-4Related news

Development of an ultra fast liquid chromatography–tandem mass spectrometry method for simultaneous determination of Cefazedone (cas 56187-47-4) and etimicin in beagle dog plasma: Application to the pharmacokinetic study of the combination of Cefazedone (cas 56187-47-4) and etimicin injections07/14/2019

A new, sensitive and efficient ultra fast liquid chromatography–tandem mass spectrometry (UFLC–MS/MS) method has been developed and validated for simultaneous quantification of cefazedone and etimicin in beagle dog plasma. After addition of the internal standard (IS) metronidazole, plasma samp...detailed

56187-47-4Relevant articles and documents

Synthesis technology of cefazedone

-

Paragraph 0043-0051, (2019/11/21)

The invention discloses a synthesis technology of cefazedone. A compound II reacts with 7-ACA to prepare a compound III, and the compound III reacts with a compound IV to prepare the product cefazedone (I). The technology has the advantages of simple synthesis route, mild reaction conditions, shortening of the reaction period, reduction of the production cost, increase of the total yield and the purity of the product, and suitableness for industrial production.

Preparation method of cefazedone

-

Paragraph 0013; 0014; 0046; 0047; 0048; 0049; 0050-0054, (2017/08/29)

The invention discloses a preparation method of cefazedone. A starting material 7-amino acetoxyl-removed cepham acid (II) reacts with 3,5-dichloro pyridone acetate (III) to prepare a compound IV, the compound IV performs substitution reaction to obtain a compound V, the compound V reacts with 2-sulfydryl-5-methyl-1,3,4-thiadiazole to obtain a final product cefazedone. The cheap starting material reacts with a condensing agent, the reaction process is controllable, the operation is simple, the purity and the yield are high, and the method is suitable for industrial production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 56187-47-4